Abbott Laboratories (BCBA:ABT)

Abbott Laboratories Statistics

Total Valuation

BCBA:ABT has a market cap or net worth of ARS 305.44 trillion. The enterprise value is 313.30 trillion.

Market Cap	305.44T
Enterprise Value	313.30T

Important Dates

The next estimated earnings date is Thursday, January 22, 2026.

Earnings Date	Jan 22, 2026
Ex-Dividend Date	Oct 15, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.04%
Shares Change (QoQ)	-0.08%
Owned by Insiders (%)	0.47%
Owned by Institutions (%)	80.74%
Float	1.73B

Valuation Ratios

The trailing PE ratio is 16.00 and the forward PE ratio is 22.15.

PE Ratio	16.00
Forward PE	22.15
PS Ratio	5.08
PB Ratio	4.35
P/TBV Ratio	10.42
P/FCF Ratio	32.22
P/OCF Ratio	24.44
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.25, with an EV/FCF ratio of 33.05.

EV / Earnings	16.42
EV / Sales	5.04
EV / EBITDA	18.25
EV / EBIT	25.66
EV / FCF	33.05

Financial Position

The company has a current ratio of 1.70, with a Debt / Equity ratio of 0.25.

Current Ratio	1.70
Quick Ratio	1.09
Debt / Equity	0.25
Debt / EBITDA	1.07
Debt / FCF	1.88
Interest Coverage	16.93

Financial Efficiency

Return on equity (ROE) is 30.62% and return on invested capital (ROIC) is 9.03%.

Return on Equity (ROE)	30.62%
Return on Assets (ROA)	6.79%
Return on Invested Capital (ROIC)	9.03%
Return on Capital Employed (ROCE)	12.38%
Revenue Per Employee	527.08M
Profits Per Employee	167.42M
Employee Count	114,000
Asset Turnover	0.55
Inventory Turnover	2.84

Taxes

Income Tax	-8,002.35B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +48.90% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+48.90%
50-Day Moving Average	48,824.60
200-Day Moving Average	42,951.03
Relative Strength Index (RSI)	43.21
Average Volume (20 Days)	1,090

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.49

Income Statement

In the last 12 months, BCBA:ABT had revenue of ARS 60.09 trillion and earned 19.09 trillion in profits. Earnings per share was 10,910.24.

Revenue	60.09T
Gross Profit	33.80T
Operating Income	11.81T
Pretax Income	11.15T
Net Income	19.09T
EBITDA	16.10T
EBIT	11.81T
Earnings Per Share (EPS)	10,910.24

Balance Sheet

The company has 10.60 trillion in cash and 17.78 trillion in debt, giving a net cash position of -7,184.16 billion.

Cash & Cash Equivalents	10.60T
Total Debt	17.78T
Net Cash	-7,184.16B
Net Cash Per Share	n/a
Equity (Book Value)	70.26T
Book Value Per Share	40,159.63
Working Capital	14.06T

Cash Flow

In the last 12 months, operating cash flow was 12.50 trillion and capital expenditures -3,017.84 billion, giving a free cash flow of 9.48 trillion.

Operating Cash Flow	12.50T
Capital Expenditures	-3,017.84B
Free Cash Flow	9.48T
FCF Per Share	n/a

Margins

Gross margin is 56.26%, with operating and profit margins of 19.65% and 31.88%.

Gross Margin	56.26%
Operating Margin	19.65%
Pretax Margin	18.56%
Profit Margin	31.88%
EBITDA Margin	26.79%
EBIT Margin	19.65%
FCF Margin	15.78%

Dividends & Yields

This stock pays an annual dividend of 452.09, which amounts to a dividend yield of 0.93%.

Dividend Per Share	452.09
Dividend Yield	0.93%
Dividend Growth (YoY)	45.27%
Years of Dividend Growth	11
Payout Ratio	28.93%
Buyback Yield	0.04%
Shareholder Yield	0.97%
Earnings Yield	6.25%
FCF Yield	3.10%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 22, 2020. It was a forward split with a ratio of 2.

Last Split Date	Oct 22, 2020
Split Type	Forward
Split Ratio	2

Scores

BCBA:ABT has an Altman Z-Score of 5.83 and a Piotroski F-Score of 6.

Altman Z-Score	5.83
Piotroski F-Score	6